Dual antiplatelet therapy (DAPT), composed of aspirin and a P2Y12 inhibitor, isthe established standard of care post-PCI for patients with chronic coronarysyndrome and acute coronary syndrome. The gene discussed is P2RY12; the disease is acute coronary syndrome.